Gender differences in stroke prevention in atrial fibrillation in general practice: Using the GRASP-AF audit tool

International Journal of Clinical Practice

Volumn 69, Issue 8, 2015, Pages 840-845

  Shantsila, E ^a   Wolff, A ^b   Lip, G Y H ^a   Lane, D A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Whinfield Medical Practice   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; COHORT ANALYSIS; DIABETES MELLITUS; DRUG CONTRAINDICATION; DRUG UTILIZATION; FEMALE; GUIDANCE ON RISK ASSESSMENT AND STROKE PREVENTION IN ATRIAL FIBRILLATION AUDIT TOOL; HEART FAILURE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INTERMEDIATE RISK POPULATION; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; UNITED KINGDOM; VERY ELDERLY; ENGLAND; EPIDEMIOLOGY; GENERAL PRACTICE; MIDDLE AGED; MORTALITY; ORAL DRUG ADMINISTRATION; REGRESSION ANALYSIS; RISK ASSESSMENT; STROKE;

ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; ENGLAND; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; STROKE;

EID: 84938206714     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12625     Document Type: Article

References (21)

1. Feinberg WM, Blackshear JL, Laupacis A, et al., Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995; 155: 469-73.
2. Lip GY, Watson T, Shantsila E,. Anticoagulation for stroke prevention in atrial fibrillation: is gender important? Eur Heart J 2006; 27: 1893-4.
3. Lane DA, Lip GY,. Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients. Thromb Haemost 2009; 101: 802-5.
4. Kerr CR, Humphries K,. Gender-related differences in atrial fibrillation. J Am Coll Cardiol 2005; 46: 1307-8.
5. Wagstaff AJ, Overvad TF, Lip GY, Lane DA,. Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? a systematic review and meta-analysis QJM 2014; 107: 955-67.
6. Pancholy SB, Sharma PS, Pancholy DS, et al., Meta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants. Am J Cardiol 2014; 113: 485-90.
7. Cove CL, Albert CM, Andreotti F, et al., Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms. Thromb Haemost 2014; 111: 385-91.
8. Sullivan RM, Zhang J, Zamba G, et al., Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM). Am J Cardiol 2012; 110: 1799-802.
9. Gomberg-Maitland M, Wenger NK, Feyzi J, et al., Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials. Eur Heart J 2006; 27: 1947-53.
10. Cowan C, Healicon R, Robson I, et al., The use of anticoagulants in the management of atrial fibrillation among general practices in England. Heart 2013; 99: 1166-72.
11. Gage BF, Waterman AD, Shannon W, et al., Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864-70.
12. Camm AJ, Lip GY, De Caterina R, et al., 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012; 33: 2719-47.
13. Inoue H, Atarashi H, Okumura K, et al., Impact of gender on the prognosis of patients with nonvalvular atrial fibrillation. Am J Cardiol 2014; 113: 957-62.
14. Dagres N, Nieuwlaat R, Vardas PE, et al., Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol 2007; 49: 572-7.
15. Kakkar AK, Mueller I, Bassand JP, et al., Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry. PLoS ONE 2013; 8: e63479.
16. Michelena HI, Powell BD, Brady PA, et al., Gender in atrial fibrillation: ten years later. Gend Med 2010; 7: 206-17.
17. Poli D, Antonucci E, Grifoni E, et al., Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment. Thromb Haemost 2009; 101: 938-42.
18. Fang MC, Singer DE, Chang Y, et al., Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation 2005; 112: 1687-91.
19. Poli D, Antonucci E, Testa S, et al., Gender differences of bleeding and stroke risk in very old atrial fibrillation patients on VKA treatment: results of the EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics). Thromb Res 2013; 131: 12-6.
20. Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY,. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study. Thromb Haemost 2012; 107: 1172-9.
21. Friberg L, Rosenqvist M, Lip GY,. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J 2012; 33: 1500-10.